Biotech Allozymes Raises $15 Million in Series A Funding, Poised to Revolutionize Industries with Enzymatic Solutions May 14, 2024
Biotech Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy May 14, 2024
Biotech BGI-HL OHA Lab inaugurated in Harbin, initiating colorectal cancer risk assessment for 800,000 May 13, 2024
Biotech SCG Cell Therapy Presented New Preclinical Data in an Oral Presentation at ASGCT 2024 Annual Meeting Highlighting Superior Tumor Inhibition of its Immunoswitch Armored HPV-TCR T Cell Therapy (SCG142) against a Broad Range of HPV-associated Cancers May 13, 2024
Biotech Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China May 12, 2024
Biotech Replicate Bioscience Presents Positive Data from Phase 1 Trial and Preclinical Data with Novel Self-Replicating RNA at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting May 11, 2024
Biotech Caliway to Present the Latest Clinical Advancements at 2024 BIO International Convention May 11, 2024
Biotech Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off May 11, 2024
Search
Biotech
May 14, 2024
May 14, 2024
May 13, 2024
May 13, 2024
May 13, 2024
May 12, 2024
May 11, 2024
May 11, 2024
May 11, 2024
May 11, 2024
